A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
Titel:
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
Auteur:
Hoyer, K. Hablesreiter, R. Inoue, Y. Yoshida, K. Briest, F. Christen, F. Kakiuchi, N. Yoshizato, T. Shiozawa, Y. Shiraishi, Y. Striefler, J.K. Bischoff, S. Lohneis, P. Putter, H. Blau, O. Keilholz, U. Bullinger, L. Pelzer, U. Hummel, M. Riess, H. Ogawa, S. Sinn, M. Damm, F.